Carbetapentane and guaifenesin and Risankizumab
Determining the interaction of Carbetapentane and guaifenesin and Risankizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / guaifenesin
Brand name: Allfen C, Allfen CX, Xpect-AT, BetaVent, Oratuss, Pulmari-GP, Certuss, Dynex VR, Carba-XP, AMBI 1000/5, Duratuss CS, Respi-Tann G, Allres-G, Tusso-ZR, Tusso-ZMR, exall, Expectuss
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbetapentane and guaifenesin-Risankizumab-rzaa topical
- Carbetapentane and guaifenesin-Risedronate
- Carbetapentane and guaifenesin-Risedronate and Calcium
- Carbetapentane and guaifenesin-Risedronate Delayed Release
- Carbetapentane and guaifenesin-Risedronate Delayed-Release Tablets
- Carbetapentane and guaifenesin-Risedronate Sodium
- Risankizumab-Carbetapentane and pseudoephedrine
- Risankizumab-Carbidopa
- Risankizumab-Carbidopa and levodopa
- Risankizumab-Carbidopa and levodopa enteral
- Risankizumab-Carbidopa and Levodopa Enteral Suspension
- Risankizumab-Carbidopa and Levodopa Extended-Release Capsules